$33.10
0.581.78%
Last update: Nov 9, 12:36 PM
Castle Biosciences Inc
CSTLNASDAQ
The average analyst price target for Castle Biosciences is $42.50, 28.4% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $40 to $52. The latest change came on Nov 9, 2026, when Baird raised its price target on Castle Biosciences from $39 to $41 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
